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Effects of high glucose on the production of heparan sulfate proteogly­
can by mesangial and epithelial cells. Changes in heparan sulfate metab­
olism may be important in the pathogenesis of diabetic nephropathy. 
Recent studies performed on renal biopsies from patients with diabetic 
nephropathy revealed a decrease in heparan sulfate glycosaminoglycan 
staining in the glomerular basement membrane without changes in 
staining for heparan sulfate proteoglycan-core protein. To understand this 
phenomenon at the cellular level, we investigated the eifect of high glucose 
conditions on the synthesis of heparan sulfate proteoglycan by glomerular 
cells in vitro. Human adult mesangial and glomerular visceral epithelial 
cells were cultured under normal (5 niM) and high glucose (25 mM) 
conditions. Immunofluorescence performed on cells cultured in 25 mM 
glucose confirmed and extended the in vivo histological observations. 
Using metabolic labeling we observed an altered proteoglycan production 
under high glucose conditions, with predominantly a decrease in heparan 
sulfate compared to dermatan sulfate or chondroitin sulfate proteoglycan. 
N-sulfation analysis of heparan sulfate proteoglycan produced under high 
glucose conditions revealed less di- and tetrasaccharides compared to 
larger oligosaccharides, indicating an altered sulfation pattern. Further­
more, with quantification of glomerular basement membrane heparan 
sulfate by ELISA, a significant decrease was obseived when mesangial and 
visceral epithelial cells were cultured in high glucose conditions. We 
concludc that high glucose concentration induces a significant alteration 
of heparan sulfate production by mesangial cells and visceral epithelial 
cells. Changes in sulfation and changes in absolute quantities are both 
obseived and may explain the earlier in vivo observations. These changes 
may be of importance for the altered integrity of the glomerular charge- 
dependent filtration barrier and growth-factor matrix interactions in 
diabetic nephropathy.
Diabetic nephropathy (DN) affects approximately 30 to 40% of 
patients with type I diabetes mellitus [1 , 2]. Histological hallmarks 
of this complication include glomerular basement membrane 
(GBM ) thickening, mesangial expansion and sclerosis due to 
increased production of extracellular matrix (ECM). This increase 
in EC M  is mainly due to an increased amount of collagen type IV, 
laminin and fibronectin, while heparan sulfate proteoglycan 
(FISPG) is relatively or absolutely decreased [3]. A  decrease in 
negatively charged molecules within the glomerular basement 
m em brane is thought to be responsible for the albuminuria seen
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in diabetic nephropathy [4]. HSPGs are believed to be im portant 
in this respect, since they consist of sulfate groups distributed 
along glycosaminoglycan side chains and these may, among other 
molecules, maintain the negative charge in the GBM [5-7]. H SPG  
is also an inhibitor of mesangial proliferation, an effect which is 
dependent on the charge distribution along the glycosaminoglycan 
(GAG) chains of H SPG  [8-10]. Vernier et al [4] showed a 
reduction of HS associated anionic sites in the lamina rara externa 
and interna of the GBM in advanced diabetic nephropathy by 
ultrastructural analysis with cuprolinic blue staining. Removal of 
HSPG by digestion with heparitinase leads to increased perm e­
ability for both ferritin [6] and albumin [5], and injection of 
antibodies to HS leads to an acute selective proteinuria in rats 
[11]. Recent immunofluorescence studies by our group on renal 
biopsies from patients with DN revealed a decrease in HS staining 
intensity in the GBM  without changes in HSPG-core protein 
staining [3]. Several studies in humans [12, 13] and models of 
experimental diabetes [14-17] have revealed changes in, or a 
decrease of, HS production in glomeruli. However, it still remains 
unclear whether these changes of FIS are absolute or relative. 
Furthermore, it is unknown whether changes concerning the 
glycosaminoglycan part of the molecule or its sulfation occur. 
Since the glomeruli in the kidney consist largely of three cell types, 
that is, endothelial, epithelial, and mesangial cells, cultures of 
these cells could provide for a useful tool to investigate the 
proteoglycan production under high glucose conditions in vitro. 
We have recently shown that glomerular visceral epithelial cells 
(GVEC) and mesangial cells (MC) each have their characteristic 
pattern of proteoglycan production and differ in heparan sulfate 
quantity [18]. Especially, G V EC are thought to be important in 
this respect, since these cells are most likely the major source of 
proteoglycans incorporated in the lamina externa of the glomer­
ular basement m em brane [19].
W e hypothesize that high glucose induces changes in HS 
production, that could differ between different cell types within 
the glomerulus. Therefore, we cultured G V EC and M C from 
human adult kidneys and investigated their proteoglycan produc­
tion under normal and high glucose conditions. These studies 
were performed using immunofluorescence and metabolic label­
ing of the cells with both Na235S 0 4 and 3H-glucosamine or 
Na235S 0 4 and 3H-leucine, followed by extensive purification 
steps. Qualitative HS alterations (N-sulfation) were assessed by
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analyzing G-25 gel filtration profiles after H N 0 2 (pH  1,5) trea t­
m ent. F u rtherm ore , an  inhibition E L IS A  using m onoclonal anti­
bodies directed against G B M  HS was used to m easu re  quantita­
tive differences in HS production.
Methods
Cell culture
M C and G V E C  were cu ltured  from  glom eruli ob ta ined  from  
norm al adult hum an kidneys th a t could not be used fo r transp lan­
ta tion  because o f  anatom ical reasons. M eth od s  used to  culture 
M C  and G V E C  have been published  previously [18, 20, 21]. The 
cells were characterized  by the ir  m orphology  and  characteristic  
im m unofluorescence staining. In brief, M C  w ere subcultured  from 
“ hillocks,” usually appearing  afte r th ree  w eeks of outgrow th  of 
the glomeruli, in 24 well p la tes  (G re iner, F rickenhausen , G er­
many) in D M E M  supp lem en ted  w ith  10% heat-inactivated fetal 
calf serum  (A FCS; Hyclone L abora to ries  Inc., Logan, U T, USA), 
trypsinized, and seeded  into T  25 o r  T  75 flasks. G V E C  were 
passaged im m ediately after outgrow ing from  th e  glom eruli (one 
week) using PBS-20 mM E D T A  into a T  25 o r  T  75 flask and 
grown in D M E M  with 5%  A FCS. C haracteriza tion  o f  MC was 
done on the basis of: (a) their cell m orphology (m ultilayer, spindle 
shaped); (b) uniform  fluorescence w ith  F IT C -phallo id in  for actin 
and positive staining w ith m onoclonal an tibodies against vimen- 
tin; (c) absence of staining using m onoclonal antibodies TN9, 
TN10 [22] and anti-von W illebrand  factor, anti-cytokeratin  and 
anti-desmin, T he  m onoclonal an tibodies T N 9  and  T N 10 specifi­
cally recognize proxim al tubu la r epithelial cells and G V E C  [22], 
respectively, and  w ere a gift o f Drs. G. M üller and M . N esper 
(M edizinische Klinik, Tübingen , G erm any). C haracteriza tion  of 
G V E C  was don e  on the basis of: (a) the ir  cell m orphology 
(confluent m onolayer o f  polygonal cells); (b) positive staining with 
m onoclonal antibodies TN10, an ti-cytokeratin  (R G E 3) (Eurodi- 
agnostics, A peldoorn , T he  N etherlands) and  an ti-C A L L A  (Dako- 
patt, Denmark); (c) absence o f staining using monoclonal antibodies 
TN9, anti-von W illebrand  fac to r and  anti-desm in. Experim ents 
were perform ed  in “ n o rm a l” (5 m M  =  D M E M  +  0.5%  A FCS) 
glucose and “ high” glucose concen tra tions  (25 m M  =  D M E M  4- 
0.5% A FCS +  20 mM D-glucose). G lucose concentra tions w ere 
checked using a glucose analyzer 2 (B eckm an, U SA ) b e fo re  and 
after each experim ent. As an  osm otic  contro l we used  an L- 
glucose (D M E M  4- 0.5%  A FC S +  20 mM L-glucose) containing 
m edium . N o insulin was ad d ed  to  e i th e r  contro l or high glucose 
media. In addition, we m easured  th e  insulin concen tra tion  (by 
Radioim m unoassay, M edgenix, Brussels, Belgium; detection limit 
3 m U /liter; coefficient o f variation at different levels below  6% ) in 
both  control and high glucose m edia contain ing  0.5 o r  2.0% A 
FCS, and did no t find detec tab le  levels of insulin.
Immunofluorescence
Cells were grown on sterile  glass coverslips (10,000 cells/well) in 
D M E M  containing 10%  A FCS. A fte r  24 hours the cells were 
starved in D M E M  contain ing  0.5%  A FCS for 24 hours. Subse­
quently, cells w ere grown for th ree  days in D M E M  with 0,5% A 
FCS alone (5 mM  glucose), 25 mM  glucose, o r 25 mM L-glucose. 
T he cells were w ashed th ree  tim es w ith  p h o sp h a te  buffered saline 
(PBS), fixed in ace tone  for five m inu tes  a t 0°C, air-dried, and 
im m unofluorescent double  staining was p e rfo rm ed  by incubating
with anti-HS m onoclonal antibodies (JM 403) [11] and anti-H SPG  
core (B31) polyclonal antibodies [23] for 30 minutes. A fter 
extensive washing with PBS, the cells were incubated with tetra- 
methylrhodamine isothiocyanate (TRITC)-conjugated rabbit 
anti-goat IgG (R A G  IgG -TR ITC ) (Nordic) followed by fluores­
cein isothiocyanate (FITC)-conjugated goat anti-m ouse IgM  
(G A M  IgM -FITC) for 30 m inutes in the dark. G A M  IgM -FITC 
and R A G  IgG -TRITC were used as controls. A fter washing three 
times with PBS, the slides were m ounted in 1,4 diazobicyclo(2, 2, 
2)octane-glycerol (DABCO-glycerol) and assessed for fluores­
cence at 340 to 380 nm  (FITC) or 560 nm (TR ITC ) and 
photographed through a Leitz microscope (W etzlar, Germ any). 
The slides were examined and scored without knowledge of the  
sample origin by two independent observers. Furtherm ore, in ten­
sity of staining was scored on a semiquantitative scale using the 
exposure time (in seconds) of the cam era as measure.
Metabolic labeling
M C and G V EC  were cultured in T  75 flasks until confluence 
and cultured overnight with D M E M  supplem ented with 2% A 
FCS. M etabolic labeling of cells in media supplem ented with a 
dose response of A FCS revealed that a 2% concentration induced 
maximal incorporation of the label (data  not shown). M edia were 
replaced by sulfate free D M E M  or sulfate and leucine free 
D M E M  with 2%  A FCS and labeled for 24 hours at 37°C using 
100 ¿¿Ci/ml N a235S 0 4 (carrier-free; New England Nuclear, Bos­
ton, M A, USA) and 25 juCi/ml 3H  glucosamine or 50 Ci/ml 
DL-(4, 5)-3H  leucine (A m ersham  International, UK). Cell label­
ing was perform ed in different culture conditions: (a) 5 mM  
glucose; (b) 25 mM glucose; and (c) 25 mM L-glucose (osmotic 
control). A fter 24 hours the cell media were separated  from the 
cells. T he  cells were washed three times with cold PBS and these 
washes were added to the cell media fraction. Cells were scraped 
into an extraction buffer using 4 m  guanidine HC1 at 4°C with the 
following protease inhibitor cocktail: 10 mM E D T A  and 5 mM 
phenylmethyl sulfonyl fluoride (PMSF), 2 mM benzamidine, 50 
mM e-aminocaproic acid, 0.5 U/ml aprotinin and 5 mM iodoacet- 
amide (all from Sigma, St. Louis, M O, USA), Both the cell m edia 
and cell extracts were extensively dialyzed against 0.5 M sodium 
acetate pH 5.8 with protease inhibitor cocktail at 4°C. The 
fractions were finally dialyzed against D E A E  buffer containing 6 M 
urea, 50 mM Tris, 0.2% chaps with protease inhibitors cocktail, p H  
7.0, and  first separated on a 5 ml D E A E  anion exchange ch rom a­
tography column. For the second and final purification the labeled 
m aterial was separated using H PLC  with a D E A E  anion exchange 
75 X 7.5 mm Bio-Gel TSK D E A E -5PW  H PLC  column (Biorad, 
R ichm ond, CA, USA). T he  bound material was eluted with an 
increasing NaCl gradient in D E A E  buffer (0.1 to 1,0 m ) ,  at a flow 
rate of 1 ml/min, with 1.0 ml fractions collected. T he conductivity 
of each fraction was m easured using a CDM3 rad iom eter conduc­
tivity m eter (Copenhagen, D enm ark) and the 35S and 3H  rad io­
activity were m easured by adding aliquots of the fractions to a 
fluorophore U ltim a G old (Packard). The separation protocol 
resulted  in different proteoglycan peaks. These peaks were dia­
lyzed against distilled water, freeze dried and stored at -2 0 °C  
until use. Characterization of the different macromolecules was 
perform ed as described previously [18]. Briefly, each of the pooled  
fractions were treated  with 0.75 m  N aO H  and 20 mM sodium 
borohydride (N aB H 4) (alkaline /3 elimination) for one hour a t 
72°C [24] followed by separation on a G50 size separation column
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run in 0.5 m sodium acetate buffer containing 0.2% chaps and 
pro tease inhibitor cocktail, pH  7.0. The G50 column was presatu­
rated  with 1 mg/ml heparin  and 10 mg/ml bovine serum albumin 
(BSA). The void volume was tested for its sensitivity to chon- 
droitinase A BC (Ch-ABC; 2.5 m U), chondroitinase A C  (Ch-AC; 
2.5 m U ) and nitrous acid pH  1.5 ( H N 0 2) [25-27]. Identification 
of the 35S/3H  glycosaminoglycans was determined by the following 
criteria: (a) molecules with sensitivity to H N 0 2 pH  1.5 without 
sensitivity to Ch-ABC or Ch-AC are designated as heparan 
sulfate; (b) molecules with sensitivity to Ch-ABC without sensi­
tivity to Ch-AC were designated as dermatan sulfate; and (c) 
molecules equally sensitive to both Ch-ABC and Ch-AC were 
referred  to as chondroitin sulfate.
Distribution o f oligosaccharides formed by nitrous acid cleavage
H SPG  isolated from  the cell m edia and cell extracts of G V EC  
were treated  with papain (1 mg/ml) for 18 hours at 55°C, and 
subsequently hea t inactivated at 100°C [28]. The material was 
centrifuged (3000 rpm) to spin down the papain. The supernatant 
was cleaved with H N 0 2 at pH  1.5, and separated into di-, tetra-, 
and higher oligosaccharides by gel filtration on a G25 sephadex 
size separation column (0.95 X 100 cm) in 0.5 m  N H 4H C 0 3 (2 
ml/hr) [29].
Heparan sulfate ELISA
H SPG  were detected using an inhibition ELISA with mouse 
monoclonal antibodies that specifically recognize GBM  HS [30], 
Cells were cultured in 12 well plates and starved overnight using 
D M E M  with 0,5% A FCS. Experiments were perform ed in 0.5% 
A FCS to induce quiescence of the cells and to minimize the 
background determ ination in ELISA. Before and after each 
experiment cell num bers were determ ined in triplicate using a 
Coulter C ounter (Coulter Electronics, Mijdrecht, The N ether­
lands). Cells were cultured for three days in (a) D M EM  with 0.5% 
A FCS alone (5 mM glucose), (b) 25 mM glucose or (c) 25 mM 
L-glucose (osmotic control). HS production of four different cell 
lines was m easured in triplicate and expressed as ^g/10fi cells/72 
hours. Since M C and G V EC  produce the complement component 
factor H, this molecule was used as a control for “normal protein” 
synthesis using a sandwich ELISA  [31]. Cell death was determ ined 
by quantification of the lactate dehydrogenase (LD H ) levels in the 
cell media.
Statistical analysis
T he data of control and experimental groups were expressed as 
m eans ±  s d . For statistical analysis we used the Student’s ¿-test for 
unpaired samples, and a P  value <  0.05 was considered significant.
Results
Immunofluorescence
Im m unofluorescence perform ed on normal cultured M C re ­
sulted in a primarily intracellular staining with an filamentous 
pattern  using bo th  anti-HS and anti-HSPG antibodies. This 
staining could be inhibited by addition of HS. Intensity of HS 
staining decreased significantly (P <  0.002) (exposure time (in 
seconds) 1.4 ±  0.01 to 3.3 ± 1 .1 )  after culturing cells in 25 mM 
glucose, when com pared to cells cultured in 5 mM glucose or 25 
mM L-glucose (Fig. 1 A, C). In contrast, no difference of staining 
intensity was observed in 5 mM glucose and 25 mM glucose treated
cells using anti-HSPG core antibodies (exposure time 9.6 ±  0.6 to
10.6 ± 1 .3 ;  Fig. 1 B, D). G V EC  showed predominately intracel­
lular staining for both antibodies. The intensity of HS staining 
after culturing these cells under high glucose (25 mM glucose) 
conditions was reduced (P <  0.02) (exposure time 45.5 ±  4.2 to
89.6 ±  10.5) when com pared to normal (5 mM glucose) conditions 
(Fig. 2 A, C). Staining of the cells grown in 25 mM L-glucose did 
not result in a change of intensity. Also, staining of cells with 
anti-HSPG core antibodies did not show any difference irrespec­
tive of the glucose concentration (exposure time 48.6 ±  1.9 to 41.5 
±  3.4; Fig. 2 B, D)
Metabolic labeling
M C and G V EC  were labeled as described in Methods. The cell 
media and cell extracts were harvested and the proteoglycans 
were purified as described. The chemical characterization of the  
different proteoglycans obtained, has been described previously 
[18]. Briefly, cell media of MC (Fig. 3 A-C) contained one 
glycoprotein and the proteoglycans HS (I) (51% of the total 
35S-proteoglycan production) and dermatan sulfate (II) (49%). 
The cell extracts of these cells consisted of (I) HS (58%) and 
derm atan sulfate (42%) (II) (Fig. 3 D-F). The cell media o f 
G V EC  (Fig. 4 A,B) consisted of three glycoproteins and the 
proteoglycans HS (I) (62%) and a hybrid molecule of both 
chondroitin sulfate and HS (38% )(II). The cell extracts contained 
the proteoglycans HS (I) (79%) and chondroitin sulfate (II)(21% ) 
(Fig. 4 C,D). The nature of H SPG  produced by G V EC  and M C 
was studied in detail [18] and are important for the interpretation 
of this study. In brief, by SDS-PAGE we found a 400 kD core 
protein of H SPG  isolated from both the cell media and cell 
extracts of GVEC. This molecular weight of 400 kD correlated 
well with the molecular weight of perlecan, the large basem ent 
membrane HSPG. Furtherm ore, expression of this type of H SPG  
was found using RT-PCR. Peak fractions containing H SPG  (as 
documented by sensitivity to H N 0 2 treatment) reacted positive in 
an ELISA system using antibodies recognizing perlecan. Finally, 
HSPG isolated from both the cell media and cell extracts of 
G V EC and M C were subjected to size separation chromatography 
using a H R  200 sephadex column (HPLC). HSPG isolated from  
G V EC and M C eluted at a Kav of 0.047 and 0.058, respectively, 
at which molecules with a molecular weight around 400 kD 
normally elute.
Absolute differences in proteoglycan production cannot be 
given with the methods used for isolation since we had to employ 
two purification steps, first a 5 ml D EA E column and finally a 
H PLC -D EA E column. The first purification gave variable recov­
eries. Therefore, we compared production of HS to other pro teo­
glycans. This was done by determining the ratio of proteoglycan 
production of HS (peak I) over other proteoglycans (peak II). 
Culturing M C under high glucose conditions resulted in the 
following changes:
(1) H PLC profiles of the cell media were altered (Fig. 3 A, B), 
as reflected by decreased Na235S 0 4 ratios and 3H  glucosamine 
(peak I/II). M ean ratios of three experiments showed a 2,2-fold 
decrease for the N a235S 0 4 (1.1 ±  0.3 to 0.5 ±  0.1) and 2.3-fold 
decrease for 3H  glucosamine (1.3 ±  0.3 to 0.6 ±  0.1) ratios (Table 
1 ).
(2) The H PLC  profiles of the cell extracts changed (Fig. 3 D, 
E). T he mean N a235S 0 4 ratio (peak I/ll) did not change (1.4 ±  0,1
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Fig. 1. Immanofluorence pattern of mesangial 
cells cultured under normal or high glucose 
conditions,  Cells were grown on. sterile 
coverslips, fixed with acetone and subsequently 
stained with either anti-HS monoclonal
control; c, 25 mM glucose) or 
with anti-HSPG-core polyclonal antibodies 
control; d, 25 mM glucose). GAM IgM-FITC 
(e) and RAG IgG-TRITC (f) were used as
negative controls.
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Distribution o f oligosaccharides formed by nitrous acid cleavage
HS isolated from the cell media and cell extracts of GVEC 
3 to 1.5 ± 0.2) and the *H glucosamine grown in 5 or 25 mM glucose media were separated as described
in methods. Nitrous acid treatment at pH 1.5 separated HS in di-
4
0.5 to 1.8 ± 0.6; Table 2).
the cell extracts of these revealed an tetra~(peak II) and larger (peak I) oligosaccharides
4 C, D). The three different (Fig, 5). Peaks I, II and III were combined as shown in Figure 5 
respect since the Na
3.7 to 0.7, 3.9 to 2.6 or LI to 0.6
■b....yj1
3
to 0.8, 3.9 to 2.8
SG4 and analyzed for H glucosamine (Table 3). When no discernible
peak was obtained we calculated the cpm in the fraction which 
eluted at the same Kav as the original peak fraction (represents 
1.1 to 0.6 in the three cell lines that were molecules with the same molecular weight).
Around 66% of the 3H labeled HS isolated from the ceil media 
in HS to of GVEC grown in 5 mM glucose cleaved into di- and tetrasac-of hi ehO' on.
core we charides ,  whereas
with Na ■'SO4
,>"1
H~ leucine
H-leucine in the proteoglycans they produced (data
was either not cleaved or cleaved into
HS obtained from. GVEC (cell media) grown 
m.M glucose resulted in a different cleavage pattern that is,
not shown) as has been published previously [25]. Therefore, the di- and tetrasaccharides and larger (49%).
M C
from these
to controls.
only depicted for Nitrous acid treatment of HS obtained from the cell extracts of 
ig. 3C) to 25 mM GVEC (5 mM) resulted in 55% di- and tetrasaccharides and 45%
in a 1.4-fold in ratio of 3H~leucine of larger oligosaccharides. HS obtained, from the extract of high
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Fig. 3. HPLC-DEAE chromatography o f Na235SO4 (A, DJ, 3H-glucosamine (B, EJ, and 3H-leucine (C,F) labeled macromolecules synthesized by human
mesangial cells cultured under normal (■ , 5 mM glucose) or high (. , 25 mM glucose) conditions. Cells were labeled as described and the cell media 
and cell layers were harvested and extracted. The Figure shows the profile of the macromolecules from the cell media (A, B, C) and cell extracts (D, 
E, F) that were eluted with a NaCl gradient. The salt gradient is expressed in milliSiemens (........ , mS).
injection of antibodies to HS leads acutely to a selective protein­
uria in rats [11]. Furthermore, HSPG is known to be important in 
the self assembly and organization of the matrix in the GBM and 
mesangium. Reduction in the glomerular HSPG content may lead 
to an increased synthesis of extracellular matrix and thickening of 
the GBM [32].
Our data support the hypothesis that the diabetic milieu can 
change renal HS metabolism since high glucose conditions in­
duced an altered HS production by both adult human MC and 
GVEC in vitro. This phenomenon was found using three different 
methods: immunofluorescence, metabolic labeling and quantifi­
cation by ELISA. Immunofluorescence clearly showed a de­
creased staining of HS, for both MC and GVEC when grown 
under high glucose conditions, whereas staining for the HSPG 
core protein remained unchanged. These results were consistent 
with the in vivo histological observations in kidneys with diabetic
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Table 1. Influence of high glucose (25 mM) on the production of 
heparan sulfate (HS) and dermatan sulfate (DS) by human mesangial 
cells both excreted (media) and cell associated (extract)
HS/DS
Na235S 0 4
HS/DS
3H glucosamine
5 mM: 25 mMa 5 mM 25 mM
Media 1 0.9 0.5 ( l . l )b 1.2 0,6 ( l,0)b
2 1.0 0.6 1.1 0.7
3 1.4 0.5 1.6 0.5
Extract 1 1.5 1.1 ( l . l ) b 1.0 0.6 ( l . l )b
2 1.3 1.1 1.0 0.9
3 1.5 1.3 1.7 0.5
Results arc expressed as HS/DS ratios as assessed by Na235S04 and 
3H-glucosamine labeling. 
a Concentration of glucose in culture medium 
b Ratios obtained after culture in L-giucose containing media
nephropathy [3,32]. Using the same antibodies, a decreased GBM 
HS staining was observed in biopsies from patients with overt 
diabetic nephropathy, while the staining for H SPG  core remained 
unchanged. N o differences in staining for HS or H SPG  core were 
observed when cells were cultured with 25 mM L-glucose instead 
of 25 mM D-glucose. L-glucose is not taken up by cells, but does 
create the sam e high osmotic environment. The (unchanged) 
staining intensity was similar to that of cells grown in 5 mM 
D-glucose, and indicates that the observed changes were not due 
to an osmotic effect.
Table 2, Influence of high glucose (25 niM) on the production of 
heparan sulfate (HS) and chondroitin sulfate (CS) by human 
glomerular epithelial cells both excreted (media) and cell associated
(extract)
HS/HSCS
Na235S04
HS/HSCS 
3H glucosamine
5 mM' 25 mMa 5 mM 25 mM
Media 1 2.0 1.6 1.9 1.8
2 1.6 1.5 2.3 2.4
3 1.3 1.2 (1.3)h 1.3 1.2 ( l . l)b
HS/CS HS/CS
Na235S04 3H glucosamine
Extract 1 3.7 0.7 3.8 0.8
2 3.9 2.6 3.9 2.8
3 1.1 0.6 (1.1)b 1.1 0.6 (1.3)h
Results are expressed as HS/CS ratios as assessed by Na23iS 0 4 and 
3I-I-glucosamine labeling.
0 Concentration of glucose in culture medium 
b Ratios obtained after culture in L-glucose containing media
To further investigate the effects of high glucose on the HSPG 
production com pared to HS-GAG, we performed metabolic dual 
labeling with Na233S 0 4 and 3H-glucosamine, to investigate the 
effect of “high glucose” conditions on Na235S 0 4 compared to 
3H-labeled glycosaminoglycan side chains, or with 35S-sulfate and 
3H-leucine to compare 35S-labeled glycosaminoglycan side chains
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Fig. 5. G25 sephadex fractionation o f heparan 
sulfate deamination products obtained from  
glomerular visceral epithelial cells, Heparan 
sulfate excreted in the cell media (A) and 
isolated from die cell extracts (B) of GVEC 
grown in 5 or 25 mM glucose were treated with 
nitrous acid pH 1.5. The products were 
chromatographed on a 0,95 x  100 cm G25 
sephadex column in 0.5 m NH4H C 03. Fractions 
of 1 ml were collected and analyzed for 3H. 
Fractions were pooled as indicated by the bars. 
Fraction III represents the disaccharides, II the 
tetrasaccharides and 1 the larger 
oligosaccharides.
Table 3. Distribution of oligosaccharides formed by nitrous
acid cleavage
Size
class Peak11
3 FI GAG %total
Cell media Cell extract
5 25 5 25
Di- III 35 27 24 11
Tetra- II 31 24 31 43
Higher 1 34 49 45 47
Heparan sulfate isolated from the cell media and cell extract of GVEC 
were cleaved by nitrous acid pH 1.5. The obtained fragments were 
separated by G25 gel filtration chromatography. 
a Figure 5
to the 3H-labeled core protein. After separation of the proteogly­
cans by DEAE-anion exchange chromatography, we calculated 
the ratio of both Na235S 0 4 and 3H incorporation in HS/CSHS or 
HS/CS for GVEC and HS/DS for M C  With this method we 
observed no changes in HS secreted in the cell media by GVEC, 
as compared to the hybrid molecule (CSHS) for the Na235S 0 4 or 
3H glucosamine ratios. For MC we observed a decrease in both 
HS/DS 3H glucosamine ratio and HS/DS Na235S 0 4 ratio and a 
slight decrease in the 3H leucine ratio. For both cell types we 
found decreased HS/DS and HS/CS 3H glucosamine ratios, 
respectively, when analyzing the cell extracts. This overall de­
crease in ratio of HS compared to either DS or CS may indicate 
either: (a) an absolute decrease in HS production without affect­
ing the DS or CS production; or (b) a decrease in HS and an 
increase in DS or CS production; or (c) unchanged HS production 
and increased DS or CS production. The decrease in 3H leucine 
HS/DS ratio observed when analyzing the media of MC is difficult 
to interpret since the HSPG-core protein staining by IF remained 
unaltered. However, this apparent discrepancy can be explained 
by the fact that polyclonal antibodies against HSPG core protein 
predominantly stain the cells intraceliularly. This observation is 
therefore in agreement with the unchanged 3H leucine HS/DS 
ratio in the cell extract, which contains both intracellular and 
extracellular components. The unchanged Na235S 0 4 and de­
creased 3H glucosamine ratios observed when analyzing the cell 
extracts of MC could indicate either an oversulfation of HS or 
undersulfation of DS.
To quantitate the change in HS production by GVEC and MC 
under high glucose conditions in vitroy we measured the HS 
content in the cell media using a specific GBM HS inhibition
Table 4. Production of heparan sulfate in four different cell lines of 
mesangial cells (MC) and visceral epithelial cells (GVEC), cultured 
under normal (5 mM) or high glucose (25 mM) conditions
Cell
l in e #
Heparan sulfate /Lig/106 cells/72 hr
MC GVEC
5 mM1 25 mMf 5 mM 25 mM
1 38.9 ± 2.7 18.7 ± 2.8a 282.3 ± 88.3 124.3 ± 28.4e
2 40.7 ± 5.4 11.3 ± 3.0b 276.4 ± 43.9 123.0 ± 70.8d
3 29.8 ± 8.0 5.1 ± 2.1a 225.6 ± 10.9 115.4 ± 9.2b
4 35.2 ± 8.8 8.1 ± 2,8a 216.7 ± 38.0 C
Heparan sulfate was measured in the cell media using the heparan 
sulfate inhibition ELISA. HS concentration was measured in triplicate and 
expressed in jitg/106 cells/72 hr.
fl P <  0.01, b P < 0.002,c P <  0.02, J P  <  0.05,0 undetectable,f glucose 
concentration in medium
ELISA [30]. De novo synthesized HS by MC was significantly 
decreased when cells were cultured in high glucose containing 
media as compared to control media. This decrease was observed 
in four different cell lines, For GVEC we observed a less 
pronounced, but also significant reduction in HS synthesis, when 
cells were grown in the presence of 25 mM glucose as compared to 
control media (5 mM glucose). The observed effect was not due to 
changes in cell numbers, since these did not differ significantly 
between “normal” and “high” glucose conditions, and further­
more, all HS levels were corrected for cell number. There were no 
differences in overall protein production as was shown using 
“factor H” ELISA and viability of the cells (LDH release). A dose 
response of glucose concentrations revealed a significant decrease 
in HS production when MC or GVEC were cultured in 15 mM or 
10 m M  glucose, respectively. Metabolic labeling of GVEC dem­
onstrated that incorporation and excretion of proteoglycans can 
differ between cell lines which became apparent when we analyzed 
the cell extracts of these cells. The problem of metabolic labeling 
lies in the isolation procedures necessary to obtain the different 
proteoglycans. This makes estimates of quantities in absolute 
terms rather unprecise. We therefore focused in the metabolic 
studies on relative changes comparing HS with other glycosami- 
noglycans. Changes in terms of absolute quantities were only 
studied by HS ELISA, whereas metabolic labeling not only served 
as a useful tool to identify the different proteoglycans indepen­
dently from immunological characterization studies, but also 
allowed us to study (1) changes in HS production compared with 
other proteoglycans produced and (2) ratios of sulfate and
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ÇH2OR Fig. 6. The possible heterogeneity of sulfation along the HS-GAG side chains. Molecules 
depicted in A, B and C may all function as 
building blocks of the side chain. N-sulfation as 
outlined in A, B and C would result in di-> 
tetra- or larger saccharides as shown in Figure 
5 as fractions III, II, and I, respectively. R = 
S 0 3“/H; R1 = 6 or more saccharide residues;
* either iduronic or glucuronic acid.
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Fig. 7. The effect o f increasing concentrations of 
glucose on the production of heparan sulfate by 
(A) mesangial cells and (B) glomendar visceral 
epithelial cells. MC and GVEC were cultured 
with a dose response of glucose for three days, 
cell media was harvested and assessed in the 
heparan sulfate ELISA in triplicate.
glucosamine incorporation f 18], This last parameter is of interest, 
since it has been shown that sulfation patterns of GAG side chains 
may be of significance for the specific interactions of proteogly­
cans with growth factors [33-35].
Therefore we also studied the heterogeneity in N-sulfation of 
the oligosaccharides in HS. HS molecules obtained from the cell 
media and cell extracts of GVEC grown in 5 or 25 mM glucose 
were cleaved with nitrous acid pH 1.5. Nitrous acid at pH 1.5 
specifically cleaves HS in GlcNS03 residues. To illustrate the 
underlying mechanisms, relevant chemical structures are given in 
Figure 6. Disacccharides are obtained from regions of the polymer 
chain with contiguous N-sulfated disaccharides units, and tet- 
rasaccharides are obtained from regions containing HN02-resis- 
tant GlcNAc residues [36]. Peaks I, II and III were combined as
shown in Figure 5 and analyzed for 3H glucosamine (Table 3). The 
size distribution of oligosaccharides of HS obtained from GVEC 
grown in 25 mM glucose was different from those obtained from 
GVEC grown in 5 mM glucose. Therefore, we conclude that there 
is an altered N-sulfation pattern of heparan sulfate produced by 
GVEC under high glucose conditions.
The biosynthesis of HS is cTependent on a variety of processes. 
The initiating and rate-limiting steps of these processes are the 
N-deacetylation and subsequently N-sulfation of N-acetylglu- 
cosamine; thus, C5 epimerization of D-glucuronic acid to iduronic 
acid and the many O-sulfation reactions cannot occur until 
N-sulfation has been initiated [37]. The differences in N-sulfation 
are compatible with the idea that high glucose induces a change in 
N-deacetylase activity, a hypothesis which has also been suggested
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by others [38, 39]. U nger e t al [39] observed th a t hepatocytes from 
strep tozotocin-d iabetic  ra ts  expressed less N -deacetylase activity 
than  control rats. R ecen t studies from  Ishihara et al [36] dem on­
stra ted  that h epa ran  sulfate-N -deacetylase/N -sulfotransferase 
(N SN dA c/N ST) catalyzes bo th  the N -deacetylation  and  N-sulfa­
tion of g lucosam ine residues in HS. T he  level o f H S-N dA c/N ST 
expression is im po rtan t in regulating  the form ation  o f  large fully 
N-sulfated, highly O -sulfated dom ains in HS. These dom ains have 
high affinity for basic fibroblast grow th fac to r (bF G F ) and changes 
in these dom ains may therefo re  be im po rtan t for cell growth and 
m atrix production. O u r results a re  com patib le  with the hypothesis 
that the HS produced  u n d er  high glucose conditions might 
in teract differently with growth factors because o f  an altered 
sulfation pattern .
So far, in vitro studies using m etabolic  labeling, revealed  only 
changes of total labeled pro teoglycan  p roduc tion  by hu m an  fetal 
M C  [40] or ra t M C  [41], S tudies utilizing m etabolic  labeling of 
streptozotocin-induced diabetic rats [14] w ith N a 235S 0 4 revealed 
30 to 40% decreased  inco rpo ra tion  in to  the  g lom eru lar extracel­
lular m atrices w hen com p ared  to con tro l animals. Silbiger et al 
[41] investigated th e  to ta l p roduc tion  of proteoglycans by rat M C 
under norm al and  high glucose conditions and  found no differ­
ences. However, these  findings could be due to a relative decrease 
in HS production  and  a relative increase in DS production , since 
the production o f  the  individual com ponents  was not studied. To 
o u r knowledge, no data  are available concerning the negative 
charge of hum an  G B M -H SPG  from  pa tien ts  with diabetic ne­
phropathy  or diabetes. In  vivo ev idence fo r  an a lte red  G A G  
synthesis and norm al ra tes  o f  H S P G  co re  p ro te in  were described 
by our group [3, 32]. D a ta  from  experim ental anim als were 
published by several authors. Klein* Brow n and  O egem a [42] 
studied G B M -H S P G  isolated from  m etabolically  labeled  glom er­
uli obtained from  strep tozo tocin  induced  d iabetic  rats. T h is  group 
found less 35S-proteoglycans in d iabetics com pared  to control. A 
decrease of H S P G  was only found  ín th e  rapidly m etabolized pool 
of HS. However, no  changes w ere  found  in the  hydrodynam ic size 
or charge of these m olecules. E v idence for decreased  synthesis of 
basem ent m em brane-specific proteoglycans in diabetes also came 
from work of R ohrbach  e t al [15] showing tha t less H S P G  was 
synthesized by B M -producing  tum ors (E H S ) grown in diabetic 
mice despite an unchanged  p ro te in  synthesis. N o data  concerning 
the negative charge was given. Finally, C ohen, K lepser and Wu 
[43] found a decrease in sulfate to u ro n a te  ra tio  in H S P G  isolated 
from  the G B M  o f s trep tozotocin  induced  diabetic rats, indicating 
reduction  in charge.
In conclusion, our results d em o n stra te  th a t h igh glucose condi­
tions lead to alterations in HS p ro d u c tio n  by h um an  adu lt G V E C  
and M C  in that the re  is a decreased  p roduc tion  and a changed 
p a tte rn  of N-sulfation. T hese  a ltera tions may cause a decreased 
concen tra tion  o f  an a lte red  H S P G  in th e  g lom erulus and  thus lead 
to album inuria (by a decreased  charge barrie r)  and mesangial 
expansion (by a decreased  in terac tion  w ith growth factors such as 
F G F ) observed in vivo in d iabetic  nephropathy .
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